Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
103 studies found for:    "Kidney Diseases, Cystic"
Show Display Options
RSS Create an RSS feed from your search for:
"Kidney Diseases, Cystic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Contrast-enhanced Ultrasound of the Kidney
Conditions: Chronic Kidney Disease;   Cystic Kidney Disease
Intervention: Drug: Perflutren lipid microsphere
2 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
3 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
4 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
5 Completed Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: pravastatin;   Drug: Placebo
6 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
7 Completed Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome
Conditions: Joubert Syndrome;   Cerebello-oculo-renal Syndromes
Intervention: Biological: Whole blood sample
8 Not yet recruiting Feasibility Study of Metformin Therapy in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Drug: Placebo
9 Recruiting Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
10 Not yet recruiting A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
11 Recruiting Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: tolvaptan
12 Not yet recruiting CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
Condition: Ureteropelvic Junction Obstruction
Interventions: Device: ultrasonography;   Device: diuretic renography
13 Recruiting Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
Condition: ADPKD
Intervention: Other: water
14 Not yet recruiting The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Device: Vessix
15 Recruiting Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Condition: Polycystic Kidney Diseases
Intervention: Other: No intervention
16 Not yet recruiting Efficacy of Tolvaptan on ADPKD Patients
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan
17 Recruiting Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty
Condition: Ureteropelvic Junction Obstruction
Interventions: Other: internal Double-J stents;   Other: External Stent
18 Recruiting Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Interventions: Drug: Pioglitazone;   Drug: Placebo
19 Recruiting Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Other: Placebo
20 Active, not recruiting Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Drug: tesevatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years